About Scinopsis
Scinopsis is a Healthcare company based in Frejus (France) founded in 2006 by Helen Baldwin, and was acquired by Veristat in June 2023. Semiconductor and power electronic devices are manufactured for various sectors. Scinopsis offers products and services including Medical Writing, Regulatory Consulting, and Clinical Operations. Its focus areas include Biopharma Outsourcing, Consulting, Regulatory Affairs and Medical Writing. Its legal entity is Veristat, LLC.
Company details
The company was founded in 2006 in Frejus, France, where semiconductor and power electronic devices are produced. Products such as diodes, MOSFETs, integrated circuits, power modules, and conditioners are offered for applications in mobility, energy, industrial equipment, telecommunications, and home appliances. Development is directed toward energy efficiency improvements, gallium oxide devices, and contactless charging systems. Support services include FAQs, catalog downloads, and details on discontinued products.
Products & Services of Scinopsis
Scinopsis offers a comprehensive portfolio of products and services, including Medical Writing, Regulatory Consulting, and Clinical Operations.
Creates regulatory documents for drug development processes.
Provides advice on regulatory submissions and compliance.
Manages project and site monitoring for trials.
Apps and channels of Scinopsis
its YouTube channel Veristat has 208 subscribers and 30 videos.
Videos from Scinopsis
The most watched videos on Scinopsis's YouTube channel, Veristat (208 subscribers). Click a video to play it here.
More on Veristat.
Investors in Scinopsis
Scinopsis has secured backing from 1 investor. Prominent investors backing the company include Veristat.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical trials and regulatory submissions are supported as a CRO. | 1994 | veristat.com | Southborough, United States |
Investor details for Scinopsis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Scinopsis
1 people are tracked at Scinopsis (1 in leadership).
| Name | Role | Group |
|---|---|---|
Helen Baldwin | Founder | Leadership |
Complete people profiles for Scinopsis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Scinopsis
2 dated milestones of Scinopsis across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Scinopsis is founded.
- Exit Acquired by Veristat.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Scinopsis
Complete news archive for Scinopsis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scinopsis
Scinopsis was founded in 2006.
Scinopsis is headquartered in Frejus, France. It is registered at Frejus, Var, France.
The company was founded in 2006 in Frejus, France, where semiconductor and power electronic devices are produced. Products such as diodes, MOSFETs, integrated circuits, power modules, and conditioners are offered for applications in mobility, energy, industrial equipment, telecommunications, and home appliances. Development is directed toward energy efficiency improvements, gallium oxide devices, and contactless charging systems. Support services include FAQs, catalog downloads, and details on discontinued products.
Scinopsis offers Medical Writing, Regulatory Consulting, and Clinical Operations.
Scinopsis has 1 investor. Key investors include Veristat.
Scinopsis operates through Veristat, Llc.
Yes. Scinopsis was acquired by Veristat in June 2023.